Real-world evidence study finds no new-onset diabetes or drug-related hyperglycemia in Pompe disease patients treated with avalglucosidase alfa

Avalglucosidase alfa therapy for Pompe disease is diluted in dextrose 5% solution in water (D5W) for infusion, which raises questions about the potential for hyperglycemia or worsening diabetes. Using United States insurance claims data, we assessed the impact of biweekly infusions on hyperglycemia,...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Alexandra Dumitriu, Ann Lucas, Raffaella Colzani
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-03-01
Sarja:	Molecular Genetics and Metabolism Reports
Aiheet:	Avalglucosidase alfa Pompe disease Hyperglycemia Diabetes mellitus Insulin resistance Prediabetes
Linkit:	http://www.sciencedirect.com/science/article/pii/S221442692400017X
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!